Brought to you by

Week ending March 6, 2015:

Recent Health Care M&A Deals




Behavioral Health Care

Acadia Healthcare Company

Quality Addiction Management

$53 million

Epic Health Services

Clarity Service Group



Prime Healthcare Services

Mercy Suburban Hospital

$30 million

Community Health Systems, Inc.

5 Oklahoma hospitals


Medical Devices

Boston Scientific Corporation

American Medical Systems urology portfolio

$1.6 billion

Cardinal Health Inc.


$1.94 billion

Nikon Corporation


$400 million

AbbVie Wins Pharmacyclics
Everybody hates a winner, it seems. Last week’s announcement that AbbVie Inc. (NYSE: ABBV) won the bidding war for Pharmacyclics Inc. (NASDAQ: PCYC) had many analysts shaking their heads in disbelief. The consternation was over the price, which at $261.25 per share for PCYC came to approximately $21 billion, about 27.8x revenue and 165.6x EBITDA. The real prize for AbbVie is Imbruvica, an effective treatment against a form of leukemia and other diseases that Pharmacyclics is marketing under an agreement with Johnson & Johnson (NYSE: JNJ). J&J and Pfizer (NYSE: PFE) were also in the final round of bidders. AbbVie’s shares fell nearly 6% on March 5, the day after the announcement, despite AbbVie CEO Richard Gonzalez’s assurances that Imbruvica can generate sales of $7 billion, after J&J takes its cut.

What U.S. Health Care Companies Are Buying Overseas
We’re hosting a webinar on March 12 called  Cross-Border M&A: Opportunities and Issues. As a run-up to it, here’s a peek at what U.S. health care companies have bought overseas in 2015, excluding the typical pharma/biotech rights and licensing deals. We’ve seen 13 acquisitions of foreign companies so far, better than the 10 recorded in the same period in 2014. In the first two months of this year, $2.3 billion has been committed to those transactions. See the chart below.

Cross-Border Health Care Deals by U.S. Companies, 2015




Cyberonics Inc.

Sorin S.p.A.

$1.2 billion

Mylan Inc.

Famy Care women’s health busienss

$750 million

Biogen Idec

Covergence Pharmaceuticals

$200 million

Intrexon Corporation


$60 million

Lexmark International

Claron Technology

$37 million

Source: The Health Care M&A Information Source, March 6, 2015

Community Health Systems Buys into Five Oklahoma Hospitals
Community Health Systems, Inc. (NYSE: CYH) bought out its joint venture partner, INTEGRIS Health, to take full title to five hospitals in Oklahoma: Blackwell Regional Hospital (53 beds), Clinton Regional Hospital (56 beds), Marshall County Medical Center (25 beds), Mayes County Medical Center (52 beds) and Seminole Medical Center (32 beds). The five hospitals were previously owned through a joint venture between INTEGRIS and subsidiaries of Health Management Associates, Inc., which Community Health announced it would acquire in July 2013, for $7.6 billion. No price was disclosed on this deal.

Nikon Refocuses on Medical Devices
Nikon Corporation (T: 7731) is following its consumer electronics brethren, Canon, Inc. (NYSE: CAJ), FujiFilm (T: 4901), Olympus Corp. (T:7733), Pentax Corp. and Royal Philips (NYSE: PHG), into the health care industry. Last week it announced the acquisition of Optos. The $400 million price buys a Scottish medical device company that specializes in designing retinal-imaging machines used to test eyes and detect high blood press, and certain types of cancers………………..Click here for a free trial to The Health Care M&A Information Source and download the current issue today.

Around the Web in Health Care M&A…Click here to see more

Webcast Calendar…Click here to see more

Upcoming Investor Conferences…Click here to see more

Previous Issues of Health Care Deal News…Click here to see more